HK Stock MarketDetailed Quotes

02197 CLOVER BIO-B

Watchlist
  • 0.290
  • +0.005+1.75%
Trading Dec 12 14:48 CST
376.15MMarket Cap-0.39P/E (TTM)

CLOVER BIO-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax
-114.62%-95.12M
94.35%-138.54M
157.27%650.62M
59.25%-2.45B
13.59%-1.14B
-559.03%-6.02B
---1.31B
-1,779.05%-912.9M
---48.58M
Profit adjustment
Interest (income) - adjustment
-33.50%-13.11M
-89.47%-16.12M
-111.09%-9.82M
21.88%-8.51M
-54.67%-4.65M
-219.54%-10.89M
---3.01M
-335.25%-3.41M
---783K
Impairment and provisions:
-99.84%1.93M
236.96%1.72B
4,496.96%1.24B
669.31%509.8M
--26.91M
--66.27M
----
----
----
-Impairment of property, plant and equipment (reversal)
----
--2.1M
----
----
----
----
----
----
----
-Impairmen of inventory (reversal)
-99.84%1.93M
256.87%1.7B
16,717.90%1.24B
617.77%475.64M
---7.44M
--66.27M
----
----
----
-Other impairments and provisions
----
-46.37%18.32M
-99.41%201K
--34.16M
--34.35M
----
----
----
----
Revaluation surplus:
----
----
----
-100.01%-229K
-100.04%-229K
536.94%3.81B
--555.56M
6,564.67%597.66M
---9.25M
-Other fair value changes
----
----
----
-100.01%-229K
-100.04%-229K
536.94%3.81B
--555.56M
6,564.67%597.66M
---9.25M
Asset sale loss (gain):
-158.30%-2.09M
-43.77%4.74M
-50.86%3.59M
--8.43M
--7.31M
----
----
--6K
----
-Loss (gain) on sale of property, machinery and equipment
--16K
-99.96%3K
----
--8.43M
--7.31M
----
----
--6K
----
-Loss (gain) from selling other assets
-158.75%-2.11M
--4.74M
--3.59M
----
----
----
----
----
----
Depreciation and amortization:
-24.59%21.29M
24.38%74.74M
0.22%28.23M
136.69%60.09M
291.55%28.17M
338.95%25.39M
--7.19M
141.30%5.78M
--2.4M
-Amortization of intangible assets
24.11%3.21M
60.84%5.51M
59.11%2.58M
280.44%3.42M
576.67%1.62M
361.54%900K
--240K
32.65%195K
--147K
Financial expense
-63.04%4.34M
215.73%18.72M
439.69%11.75M
-27.82%5.93M
-67.93%2.18M
176.35%8.22M
--6.79M
-71.23%2.97M
--10.33M
Exchange Loss (gain)
-99.51%334K
37.66%34.98M
127.58%67.61M
345.53%25.41M
1,908.79%29.71M
-132.45%-10.35M
--1.48M
38,071.43%31.9M
---84K
Special items
-67.01%7.86M
-43.68%53.52M
-62.67%23.84M
-24.11%95.02M
86.37%63.87M
--125.21M
--34.27M
----
----
Operating profit before the change of operating capital
-103.70%-74.57M
199.65%1.75B
304.79%2.01B
12.45%-1.76B
-37.95%-982.83M
-621.52%-2.01B
---712.47M
-504.77%-277.99M
---45.97M
Change of operating capital
Inventory (increase) decrease
89.63%-1.68M
99.58%-8.7M
97.88%-16.2M
-170.86%-2.09B
-458.54%-763.63M
-1,428.59%-771.75M
---136.72M
-12,746.82%-50.49M
---393K
Accounts receivable (increase)decrease
4,248.36%24.1M
---24.11M
---581K
----
----
----
----
----
----
Accounts payable increase (decrease)
27.91%-123.5M
-157.86%-97.36M
-151.08%-171.32M
-73.23%168.28M
826.48%335.38M
1,361.91%628.53M
--36.2M
296.62%42.99M
--10.84M
prepayments (increase)decrease
-113.19%-4.79M
-94.83%66.29M
-89.37%36.29M
202.21%1.28B
278.24%341.53M
-589.21%-1.25B
--90.29M
-10,669.29%-182M
---1.69M
Special items for working capital changes
100.41%9.4M
-448.79%-2.43B
-554.61%-2.3B
-71.85%696.69M
91.56%506.18M
162.97%2.47B
--264.24M
9,493.25%941M
--9.81M
Adjustment items for working capital changes
----
----
----
----
----
--100K
----
----
----
Cash  from business operations
61.15%-171.03M
56.22%-744M
21.86%-440.21M
-82.99%-1.7B
-22.89%-563.38M
-296.11%-928.64M
---458.46M
1,828.17%473.52M
---27.4M
Interest received - operating
33.50%13.11M
89.47%16.12M
111.09%9.82M
-21.88%8.51M
58.79%4.65M
219.54%10.89M
--2.93M
335.25%3.41M
--783K
Net cash from operations
63.31%-157.93M
56.95%-727.88M
22.97%-430.39M
-84.23%-1.69B
-22.66%-558.73M
-292.43%-917.75M
---455.53M
1,891.81%476.93M
---26.62M
Cash flow from investment activities
Decrease in deposits (increase)
-1,751.95%-7.59M
-93.80%3.02M
-101.00%-410K
-78.13%48.65M
-12.09%40.81M
179.35%222.44M
--46.43M
-6,745.99%-280.33M
--4.22M
Sale of fixed assets
----
----
----
--2.2M
----
----
----
----
----
Purchase of fixed assets
67.31%-1.23M
90.98%-6.95M
92.92%-3.75M
-30.01%-77.03M
-50.73%-52.92M
47.85%-59.25M
---35.11M
-1,566.87%-113.61M
---6.82M
Purchase of intangible assets
70.71%-193K
92.20%-2.22M
92.81%-659K
-35.43%-28.53M
-215.10%-9.16M
-11,733.71%-21.06M
---2.91M
---178K
----
Recovery of cash from investments
----
----
----
--31.14M
--31.14M
----
----
----
----
Cash on investment
----
----
----
53.57%-13.93M
----
---30M
---29.92M
----
----
Net cash from investment operations
-87.11%-9.01M
83.57%-6.16M
-148.82%-4.82M
-133.45%-37.51M
145.84%9.86M
128.45%112.12M
---21.52M
-15,070.13%-394.12M
---2.6M
Net cash before financing
61.64%-166.94M
57.53%-734.04M
20.71%-435.21M
-114.53%-1.73B
-15.06%-548.87M
-1,072.89%-805.63M
---477.04M
383.44%82.81M
---29.22M
Cash flow from financing activities
New borrowing
-96.79%7.23M
56.82%460.79M
--225.29M
--293.83M
----
----
----
----
----
Refund
14.48%-101.91M
---444.59M
---119.17M
----
----
----
----
----
----
Issuing shares
-92.65%5K
-99.98%84K
--68K
-86.00%453.16M
----
878.36%3.24B
--1.59B
128.21%330.91M
--145M
Interest paid - financing
-183.75%-4.87M
-6,740.50%-16.55M
---1.72M
---242K
----
----
----
----
----
Issuance expenses and redemption of securities expenses
----
98.91%-54K
---54K
92.10%-4.97M
----
-555.59%-62.88M
---8.85M
-683.66%-9.59M
---1.22M
Pledged bank deposit (increase) decrease
57.45%-3.79M
50.61%-113.52M
---8.9M
---229.86M
----
----
----
----
----
Other items of the financing business
----
----
----
----
----
---102.69M
---102.69M
----
----
Net cash from financing operations
-241.13%-111.89M
-129.48%-142.41M
654.24%79.28M
-84.20%483.14M
-100.97%-14.3M
864.87%3.06B
--1.47B
123.05%316.85M
--142.05M
Effect of rate
-86.64%1.73M
-94.25%4.9M
-74.77%12.98M
23,703.88%85.21M
807.70%51.44M
98.88%-361K
---7.27M
-28,068.70%-32.16M
--115K
Net Cash
21.66%-278.82M
29.61%-876.45M
36.80%-355.93M
-155.30%-1.25B
-156.58%-563.17M
463.37%2.25B
--995.3M
254.19%399.65M
--112.84M
Begining period cash
-54.22%735.86M
-41.92%1.61B
-41.92%1.61B
436.12%2.77B
436.12%2.77B
247.15%516.18M
--516.18M
316.00%148.69M
--35.74M
Cash at the end
-63.72%458.77M
-54.22%735.86M
-43.94%1.26B
-41.92%1.61B
49.95%2.26B
436.12%2.77B
--1.5B
247.15%516.18M
--148.69M
Cash balance analysis
Cash and bank balance
-45.51%829.76M
-40.99%1.1B
--1.52B
--1.86B
----
----
----
----
--158.69M
Cash and cash equivalent balance
-45.51%829.76M
-40.99%1.1B
--1.52B
--1.86B
----
----
----
----
--158.69M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax -114.62%-95.12M94.35%-138.54M157.27%650.62M59.25%-2.45B13.59%-1.14B-559.03%-6.02B---1.31B-1,779.05%-912.9M---48.58M
Profit adjustment
Interest (income) - adjustment -33.50%-13.11M-89.47%-16.12M-111.09%-9.82M21.88%-8.51M-54.67%-4.65M-219.54%-10.89M---3.01M-335.25%-3.41M---783K
Impairment and provisions: -99.84%1.93M236.96%1.72B4,496.96%1.24B669.31%509.8M--26.91M--66.27M------------
-Impairment of property, plant and equipment (reversal) ------2.1M----------------------------
-Impairmen of inventory (reversal) -99.84%1.93M256.87%1.7B16,717.90%1.24B617.77%475.64M---7.44M--66.27M------------
-Other impairments and provisions -----46.37%18.32M-99.41%201K--34.16M--34.35M----------------
Revaluation surplus: -------------100.01%-229K-100.04%-229K536.94%3.81B--555.56M6,564.67%597.66M---9.25M
-Other fair value changes -------------100.01%-229K-100.04%-229K536.94%3.81B--555.56M6,564.67%597.66M---9.25M
Asset sale loss (gain): -158.30%-2.09M-43.77%4.74M-50.86%3.59M--8.43M--7.31M----------6K----
-Loss (gain) on sale of property, machinery and equipment --16K-99.96%3K------8.43M--7.31M----------6K----
-Loss (gain) from selling other assets -158.75%-2.11M--4.74M--3.59M------------------------
Depreciation and amortization: -24.59%21.29M24.38%74.74M0.22%28.23M136.69%60.09M291.55%28.17M338.95%25.39M--7.19M141.30%5.78M--2.4M
-Amortization of intangible assets 24.11%3.21M60.84%5.51M59.11%2.58M280.44%3.42M576.67%1.62M361.54%900K--240K32.65%195K--147K
Financial expense -63.04%4.34M215.73%18.72M439.69%11.75M-27.82%5.93M-67.93%2.18M176.35%8.22M--6.79M-71.23%2.97M--10.33M
Exchange Loss (gain) -99.51%334K37.66%34.98M127.58%67.61M345.53%25.41M1,908.79%29.71M-132.45%-10.35M--1.48M38,071.43%31.9M---84K
Special items -67.01%7.86M-43.68%53.52M-62.67%23.84M-24.11%95.02M86.37%63.87M--125.21M--34.27M--------
Operating profit before the change of operating capital -103.70%-74.57M199.65%1.75B304.79%2.01B12.45%-1.76B-37.95%-982.83M-621.52%-2.01B---712.47M-504.77%-277.99M---45.97M
Change of operating capital
Inventory (increase) decrease 89.63%-1.68M99.58%-8.7M97.88%-16.2M-170.86%-2.09B-458.54%-763.63M-1,428.59%-771.75M---136.72M-12,746.82%-50.49M---393K
Accounts receivable (increase)decrease 4,248.36%24.1M---24.11M---581K------------------------
Accounts payable increase (decrease) 27.91%-123.5M-157.86%-97.36M-151.08%-171.32M-73.23%168.28M826.48%335.38M1,361.91%628.53M--36.2M296.62%42.99M--10.84M
prepayments (increase)decrease -113.19%-4.79M-94.83%66.29M-89.37%36.29M202.21%1.28B278.24%341.53M-589.21%-1.25B--90.29M-10,669.29%-182M---1.69M
Special items for working capital changes 100.41%9.4M-448.79%-2.43B-554.61%-2.3B-71.85%696.69M91.56%506.18M162.97%2.47B--264.24M9,493.25%941M--9.81M
Adjustment items for working capital changes ----------------------100K------------
Cash  from business operations 61.15%-171.03M56.22%-744M21.86%-440.21M-82.99%-1.7B-22.89%-563.38M-296.11%-928.64M---458.46M1,828.17%473.52M---27.4M
Interest received - operating 33.50%13.11M89.47%16.12M111.09%9.82M-21.88%8.51M58.79%4.65M219.54%10.89M--2.93M335.25%3.41M--783K
Net cash from operations 63.31%-157.93M56.95%-727.88M22.97%-430.39M-84.23%-1.69B-22.66%-558.73M-292.43%-917.75M---455.53M1,891.81%476.93M---26.62M
Cash flow from investment activities
Decrease in deposits (increase) -1,751.95%-7.59M-93.80%3.02M-101.00%-410K-78.13%48.65M-12.09%40.81M179.35%222.44M--46.43M-6,745.99%-280.33M--4.22M
Sale of fixed assets --------------2.2M--------------------
Purchase of fixed assets 67.31%-1.23M90.98%-6.95M92.92%-3.75M-30.01%-77.03M-50.73%-52.92M47.85%-59.25M---35.11M-1,566.87%-113.61M---6.82M
Purchase of intangible assets 70.71%-193K92.20%-2.22M92.81%-659K-35.43%-28.53M-215.10%-9.16M-11,733.71%-21.06M---2.91M---178K----
Recovery of cash from investments --------------31.14M--31.14M----------------
Cash on investment ------------53.57%-13.93M-------30M---29.92M--------
Net cash from investment operations -87.11%-9.01M83.57%-6.16M-148.82%-4.82M-133.45%-37.51M145.84%9.86M128.45%112.12M---21.52M-15,070.13%-394.12M---2.6M
Net cash before financing 61.64%-166.94M57.53%-734.04M20.71%-435.21M-114.53%-1.73B-15.06%-548.87M-1,072.89%-805.63M---477.04M383.44%82.81M---29.22M
Cash flow from financing activities
New borrowing -96.79%7.23M56.82%460.79M--225.29M--293.83M--------------------
Refund 14.48%-101.91M---444.59M---119.17M------------------------
Issuing shares -92.65%5K-99.98%84K--68K-86.00%453.16M----878.36%3.24B--1.59B128.21%330.91M--145M
Interest paid - financing -183.75%-4.87M-6,740.50%-16.55M---1.72M---242K--------------------
Issuance expenses and redemption of securities expenses ----98.91%-54K---54K92.10%-4.97M-----555.59%-62.88M---8.85M-683.66%-9.59M---1.22M
Pledged bank deposit (increase) decrease 57.45%-3.79M50.61%-113.52M---8.9M---229.86M--------------------
Other items of the financing business -----------------------102.69M---102.69M--------
Net cash from financing operations -241.13%-111.89M-129.48%-142.41M654.24%79.28M-84.20%483.14M-100.97%-14.3M864.87%3.06B--1.47B123.05%316.85M--142.05M
Effect of rate -86.64%1.73M-94.25%4.9M-74.77%12.98M23,703.88%85.21M807.70%51.44M98.88%-361K---7.27M-28,068.70%-32.16M--115K
Net Cash 21.66%-278.82M29.61%-876.45M36.80%-355.93M-155.30%-1.25B-156.58%-563.17M463.37%2.25B--995.3M254.19%399.65M--112.84M
Begining period cash -54.22%735.86M-41.92%1.61B-41.92%1.61B436.12%2.77B436.12%2.77B247.15%516.18M--516.18M316.00%148.69M--35.74M
Cash at the end -63.72%458.77M-54.22%735.86M-43.94%1.26B-41.92%1.61B49.95%2.26B436.12%2.77B--1.5B247.15%516.18M--148.69M
Cash balance analysis
Cash and bank balance -45.51%829.76M-40.99%1.1B--1.52B--1.86B------------------158.69M
Cash and cash equivalent balance -45.51%829.76M-40.99%1.1B--1.52B--1.86B------------------158.69M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Ernst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical Companies
Pharmaceutical Companies
Intraday-0.88%